Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
5 Agosti 2026, 11:47:52
Cocaine Withdrawal
Cocaine Withdrawal is a clinical syndrome that occurs after cessation or significant reduction of cocaine use in individuals who have developed psychological or physical dependence.
Unlike alcohol or opioid withdrawal, cocaine withdrawal is usually not associated with severe medical complications, but it may cause significant psychological distress, intense craving, depression, and increased risk of suicide.
Epidemiology
Cocaine withdrawal commonly occurs among individuals with regular or heavy cocaine use
Symptoms may occur within hours to days after stopping cocaine
The severity depends on the duration and intensity of cocaine use, route of administration, and individual factors
Depression and suicidal behaviour are important concerns during the withdrawal period
Risk factors
Long-term or heavy cocaine use
Previous episodes of cocaine withdrawal
Coexisting depression or other psychiatric disorders
History of suicidal behaviour
Use of multiple substances
Poor social support
Previous unsuccessful attempts to stop cocaine use
Pathophysiology
Cocaine increases dopamine, norepinephrine, and serotonin activity by blocking their reuptake in the central nervous system. Chronic cocaine exposure leads to neuroadaptation within reward pathways. When cocaine use stops, reduced dopamine activity contributes to fatigue, depressed mood, reduced pleasure, craving, and other withdrawal symptoms.
Clinical presentation
Symptoms usually begin within hours to a few days after stopping cocaine and may persist for several weeks.
Common withdrawal symptoms
Depressed mood
Fatigue
Reduced energy
Increased sleep or insomnia
Anxiety
Irritability
Restlessness
Strong craving for cocaine
Poor concentration
Increased appetite
Important clinical concerns
Major depressive symptoms
Suicidal thoughts or behaviour
Psychotic symptoms in some individuals
Risk of relapse due to intense craving
Diagnostic criteria
Diagnosis is clinical and requires:
Cessation or reduction of prolonged cocaine use
Development of characteristic withdrawal symptoms after stopping cocaine use
Symptoms causing significant distress or impairment
Withdrawal features include:
Dysphoric mood
Fatigue
Vivid unpleasant dreams
Insomnia or excessive sleep
Increased appetite
Psychomotor agitation or retardation
Craving for cocaine
Assessment should include evaluation for depression and suicide risk.
Differential diagnosis
Major depressive disorder
Stimulant-induced depressive disorder
Alcohol withdrawal
Opioid withdrawal
Adjustment disorder
Other substance withdrawal syndromes
Medical conditions causing fatigue or mood changes
Investigations
Cocaine withdrawal is diagnosed clinically.
Assessment should include:
Clinical assessment
Detailed history of cocaine use
Assessment of withdrawal symptoms
Mental status examination
Suicide risk assessment
Assessment of other substance use
Laboratory investigations (when indicated)
Urine drug screening
Blood glucose
Full blood count
Electrolytes
Renal and liver function tests where clinically indicated
Management
Treatment goals
Support safe withdrawal
Monitor and treat depression
Prevent relapse
Address psychosocial factors contributing to cocaine use
Non-pharmacological Management
Most patients do not require hospital admission
Provide supportive counselling and reassurance
Monitor for depression and assess suicide risk
Provide psychoeducation regarding withdrawal symptoms
Encourage participation in substance use counselling programmes
Provide relapse prevention strategies
Encourage family and social support
Refer for psychological therapies where available
Pharmacological management
There is no approved substitute medication for cocaine detoxification.
For management of anxiety, agitation, or sleep disturbance:
Diazepam 5–10 mg orally every 8 hours for 5–7 days.
Notes:
Medication should be titrated according to symptom resolution
Use short-term only due to risk of dependence
Monitor for sedation and respiratory depression
Avoid prolonged benzodiazepine use
Management of depressive symptoms should follow the relevant treatment guidelines for depressive disorders.
Referral criteria
Refer to specialized clinic if:
Significant depressive symptoms
Suicidal thoughts or behaviour
Severe psychiatric symptoms
Persistent cocaine craving
Recurrent relapse
Coexisting substance use disorders
Need for specialized addiction treatment
Complications
Major depressive episodes
Suicide attempts
Relapse to cocaine use
Cocaine overdose after relapse due to reduced tolerance
Social and occupational impairment
Coexisting substance use disorders
Prevention
Early identification of cocaine use disorder
Access to addiction treatment services
Psychological support and relapse prevention programmes
Screening and treatment of mental health disorders
Family and community support
Prognosis
Cocaine withdrawal symptoms generally improve with supportive care. However, relapse risk remains high, especially during periods of intense craving and depressive symptoms. Long-term recovery improves with continued psychosocial treatment and addiction support.
Patient education
Cocaine withdrawal can cause significant mood changes but is treatable
Depression and suicidal thoughts require urgent medical attention
Avoid returning to cocaine use after stopping because relapse may increase overdose risk
Counselling and rehabilitation improve long-term recovery
Attend follow-up appointments and addiction support services
Imeandikwa:
5 Agosti 2026, 11:46:48
Disclaimer: The information on this website is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical concerns or emergencies.
Rejea za mada hii:
United Republic of Tanzania, Ministry of Health. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland. 6th ed. Dodoma: Ministry of Health; 2021.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Text Revision. Washington, DC: American Psychiatric Association Publishing; 2022.
World Health Organization. International Standards for the Treatment of Drug Use Disorders: Revised Edition Incorporating Results of Field-Testing. Geneva: World Health Organization; 2020.
National Institute on Drug Abuse. Treatment Approaches for Drug Addiction and Substance Use Disorders. Bethesda: National Institutes of Health; 2024.
